Company NurExone Biologic Inc. Toronto S.E.
Equities
ENER
CA29278Q1063
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lior Shaltiel
CEO | Chief Executive Officer | - | 21-03-31 |
Eran Ovadya
DFI | Director of Finance/CFO | - | 22-06-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Richardson
BRD | Director/Board Member | 78 | 22-01-02 |
Gadi Riesenfeld
BRD | Director/Board Member | 79 | 23-07-05 |
Yoram Drucker
CHM | Chairman | 59 | 19-12-31 |
Oded Orgil
BRD | Director/Board Member | 57 | 22-06-14 |
Lior Shaltiel
CEO | Chief Executive Officer | - | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,814,822 | 61,834,822 ( 93.95 %) | 0 | 93.95 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+23.64% | 48.09B | |
+46.90% | 40.62B | |
-2.65% | 40.43B | |
-6.20% | 28.36B | |
+8.50% | 24.89B | |
-20.03% | 19.01B | |
+28.93% | 12.09B | |
+0.01% | 11.88B | |
-0.78% | 11.8B |